These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26206270)

  • 21. A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.
    Wen F; Li L; Zhao N; Chiang MJ; Xie H; Cooley J; Webby R; Wang PG; Wan XF
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of single amino acid substitution at position 220 in the hemagglutinin glycoprotein on avian influenza H7N9 candidate vaccine virus.
    Liu L; Li Z; Zhou J; Lu J; Li X; Liu J; Xiao N; Wang D
    Virus Genes; 2021 Apr; 57(2):164-171. PubMed ID: 33606171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza virus PB1 and neuraminidase gene segments can cosegregate during vaccine reassortment driven by interactions in the PB1 coding region.
    Cobbin JC; Ong C; Verity E; Gilbertson BP; Rockman SP; Brown LE
    J Virol; 2014 Aug; 88(16):8971-80. PubMed ID: 24872588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants.
    Rudneva IA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Varich NL; Ilyushina NA; Gambaryan AS; Krylov PS; Kaverin NV
    Arch Virol; 2007; 152(6):1139-45. PubMed ID: 17294090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk.
    Zhang W; Xue T; Wu X; Zhang P; Zhao G; Peng D; Hu S; Wang X; Liu X; Liu W; Liu X
    Vaccine; 2011 Oct; 29(45):8032-41. PubMed ID: 21864614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs.
    Ridenour C; Johnson A; Winne E; Hossain J; Mateu-Petit G; Balish A; Santana W; Kim T; Davis C; Cox NJ; Barr JR; Donis RO; Villanueva J; Williams TL; Chen LM
    Influenza Other Respir Viruses; 2015 Sep; 9(5):263-70. PubMed ID: 25962412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses.
    Campbell PJ; Danzy S; Kyriakis CS; Deymier MJ; Lowen AC; Steel J
    J Virol; 2014 Apr; 88(7):3802-14. PubMed ID: 24429367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
    Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
    Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs.
    Wang W; Lu J; Cotter CR; Wen K; Jin H; Chen Z
    J Virol; 2013 Apr; 87(8):4642-9. PubMed ID: 23408613
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    An Y; Parsons LM; Jankowska E; Melnyk D; Joshi M; Cipollo JF
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds.
    Ramanunninair M; Le J; Onodera S; Fulvini AA; Pokorny BA; Silverman J; Devis R; Arroyo JM; He Y; Boyne A; Bera J; Halpin R; Hine E; Spiro DJ; Bucher D
    PLoS One; 2013; 8(6):e65955. PubMed ID: 23776579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.
    Panaampon J; Ngaosuwankul N; Suptawiwat O; Noisumdaeng P; Sangsiriwut K; Siridechadilok B; Lerdsamran H; Auewarakul P; Pooruk P; Puthavathana P
    PLoS One; 2012; 7(5):e36318. PubMed ID: 22563489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
    PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of American-Lineage Influenza H5N2 Reassortant Vaccine Viruses for Pandemic Preparedness.
    Chen PL; Hu AY; Lin CY; Weng TC; Lai CC; Tseng YF; Cheng MC; Chia MY; Lin WC; Yeh CT; Su IJ; Lee MS
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31212631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.
    Horimoto T; Takada A; Fujii K; Goto H; Hatta M; Watanabe S; Iwatsuki-Horimoto K; Ito M; Tagawa-Sakai Y; Yamada S; Ito H; Ito T; Imai M; Itamura S; Odagiri T; Tashiro M; Lim W; Guan Y; Peiris M; Kawaoka Y
    Vaccine; 2006 Apr; 24(17):3669-76. PubMed ID: 16378663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reverse genetics vaccine seeds for influenza: Proof of concept in the source of PB1 as a determinant factor in virus growth and antigen yield.
    Gíria M; Santos L; Louro J; Rebelo de Andrade H
    Virology; 2016 Sep; 496():21-27. PubMed ID: 27240145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
    Lu B; Zhou H; Ye D; Kemble G; Jin H
    J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic generation of influenza vaccine viruses for rapid response to pandemics.
    Dormitzer PR; Suphaphiphat P; Gibson DG; Wentworth DE; Stockwell TB; Algire MA; Alperovich N; Barro M; Brown DM; Craig S; Dattilo BM; Denisova EA; De Souza I; Eickmann M; Dugan VG; Ferrari A; Gomila RC; Han L; Judge C; Mane S; Matrosovich M; Merryman C; Palladino G; Palmer GA; Spencer T; Strecker T; Trusheim H; Uhlendorff J; Wen Y; Yee AC; Zaveri J; Zhou B; Becker S; Donabedian A; Mason PW; Glass JI; Rappuoli R; Venter JC
    Sci Transl Med; 2013 May; 5(185):185ra68. PubMed ID: 23677594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.